Neurogene (NGNE) Institutional Ownership → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free NGNE Stock Alerts $34.01 +0.70 (+2.10%) (As of 04:00 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Neurogene (NASDAQ:NGNE)CurrentInstitutional OwnershipPercentage52.37%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$52.59MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.03M Get NGNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NGNE Institutional Buying and Selling by Quarter Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Neurogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Janus Henderson Group PLC813,353$41.37M0.0%-3.4%6.266% 5/16/2024 Redmile Group LLC935,252$47.60M1.7%-1.2%7.205% 5/15/2024 Baker BROS. Advisors LP456,015$23.21M0.3%+0.6%3.513% 5/10/2024 Vanguard Group Inc.507,483$25.83M0.0%+906.5%3.943% 5/7/2024 SG Americas Securities LLC2,348$120K0.0%N/A0.018% 4/30/2024 Privium Fund Management UK Ltd5,860$274K0.1%N/A0.046% 2/15/2024 Great Point Partners LLC994,229$19.27M3.3%N/A42.326% 2/14/2024 Avidity Partners Management LP466,243$9.04M0.3%N/A19.840% 2/2/2024 BML Capital Management LLC24,666$478K0.4%N/A1.050% (Data available from 1/1/2016 forward) NGNE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NGNE shares? During the previous two years, 9 institutional investors and hedge funds held shares of Neurogene. The most heavily invested institutionals were Redmile Group LLC ($47.60M), Janus Henderson Group PLC ($41.37M), Vanguard Group Inc. ($25.83M), Baker BROS. Advisors LP ($23.21M), Great Point Partners LLC ($19.27M), Avidity Partners Management LP ($9.04M), and BML Capital Management LLC ($478K).Learn more on NGNE's institutional investors. What percentage of Neurogene stock is owned by institutional investors? 52.37% of Neurogene stock is owned by institutional investors. Learn more on NGNE's institutional investor holdings. Which institutional investors have been buying Neurogene stock? The following institutional investors have purchased Neurogene stock in the last 24 months: Great Point Partners LLC ($994.23K), Avidity Partners Management LP ($466.24K), Vanguard Group Inc. ($457.06K), BML Capital Management LLC ($24.67K), Privium Fund Management UK Ltd ($5.86K), Baker BROS. Advisors LP ($2.50K), and SG Americas Securities LLC ($2.35K). How much institutional buying is happening at Neurogene? Institutional investors have bought a total of 1,952,907 shares in the last 24 months. This purchase volume represents approximately $52.59M in transactions. Which Neurogene major shareholders have been selling company stock? The following institutional investors have sold Neurogene stock in the last 24 months: Janus Henderson Group PLC ($28.34K), and Redmile Group LLC ($11.65K). How much institutional selling is happening at Neurogene? Institutional investors have sold a total of 39,980 shares in the last 24 months. This volume of shares sold represents approximately $2.03M in transactions. Related Companies: ORGO Major Shareholders KRRO Major Shareholders VRCA Major Shareholders TERN Major Shareholders ANRO Major Shareholders AMRN Major Shareholders BMEA Major Shareholders ESPR Major Shareholders MREO Major Shareholders HRTX Major Shareholders This page (NASDAQ:NGNE) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
